The University of Florida Department of Urology invites you to attend Grand Rounds:
Wednesday, March 29, 2023
7:00 am – 8:00 am
Urology Conference Room M2-203C
“Diagnostic Tools for Uropathogen Detection: The Past, the Present, and a Future Trial”

Bristol Whiles, MD
Endourology/Minimally Invasive Surgery Fellowship
University of Florida
Department of Urology
LEARNING OBJECTIVES:
Upon completion of this activity, participants should be able to:
- Review current methods for uropathogen detection
- Discuss newer technologies, including PCR and next generation sequencing
- Evaluate prior studies utilizing these new technologies for urology and kidney stone patients
- Identify gaps in our knowledge and potential for future clinical trials
Disclosure
Dr. Whiles has disclosed that she is a clinical consultant for Mokan Labs, LLC a molecular diagnostic laboratory, and was previously a consultant for Integrated DNA Technologies. Planning committee member Vincent Bird, MD has disclosed that he is a consultant for Boston Scientific. No one else in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.
Accreditation
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit
The University of Florida College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For additional information, contact Stephanie Stenner at 352/273-8634 or e-mail stephanie.stenner@urology.ufl.edu
Section # 2115
